The prevention of congestive heart failure: left ventricular dilation and its management

B G Firth1, P M Dunnmon

  • 1Cardiology Division, University of Texas Southwestern Medical Center, Dallas 75235.

Insights

Left ventricular remodeling after myocardial infarction can lead to heart failure. Early interventions with nitroglycerin or captopril may help prevent this adverse cardiac remodeling.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Pathophysiology

Background:

  • Left ventricular dilation and remodeling affect 35-40% of anterior transmural myocardial infarcts.
  • These changes are key precursors to late congestive heart failure.
  • The process begins within 24 hours post-infarction and can progress over years.

Purpose of the Study:

  • To investigate the mechanisms of left ventricular remodeling post-myocardial infarction.
  • To explore potential therapeutic interventions to ameliorate adverse cardiac remodeling.

Main Methods:

  • Observational study of myocardial infarction patients.
  • Analysis of left ventricular wall changes, including thinning and hypertrophy.
  • Review of existing data on pharmacological interventions.

Main Results:

  • Left ventricular remodeling involves both infarcted and uninfarcted myocardium.
  • Cell slippage contributes to left ventricular wall thinning.
  • Compensatory hypertrophy in uninfarcted segments may become pathological, impairing pump function.

Conclusions:

  • Left ventricular remodeling is a significant complication of myocardial infarction, predisposing to heart failure.
  • Nitroglycerin and captopril show promise in mitigating this process.
  • Further research is needed to determine the role of a patent infarct-related artery.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...